| Website | shire.com/shirepl... |
| Category | BioTech |
| Employees |
| Total | $725M |
| SARcode Bioscience, 3/13 | $160M |
| Advanced BioHealing, 5/11 | |
| Movetis, 8/10 | $565M |
| NeuroPhage Pharmaceuticals | 5/13 |
| ArmaGen Technologies | 11/12 |
| Promedior | 10/12 |
| Promethera Biosciences | 3/12 |
| Prexa Pharmaceuticals | 5/11 |
| NeuroPhage Pharmaceuticals | 3/11 |
Shire PLC is a specialty biopharmaceutical company. They have a global sales and marketing infrastructure with a broad portfolio of products and direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain.